Related Tags >> FDA GlaxoSmithKline drug safety AstraZeneca

FDA approval News

Most Popular FDA approval Story

How dangerous is Effient to Plavix?

July 13, 2009 — 11:08am ET | By Tracy Staton

Just how much danger does Plavix face from the new Effient approval? Depends on who's talking. Theoretically, the new Eli Lilly/Daiichi Sankyo blood thinner could significantly eat into the... Read more...

FDA approval Press Releases

Theravance and Astellas Announce FDA Approval of VIBATIVTM (telavancin) for the Treatment of Complic
FDA Approves Valcyte (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients
Lundbeck Inc. Announces FDA Marketing Approval for Sabril for the Treatment of Two Difficult-to-Treat Epilepsies
Mylan Receives FDA Approval for Generic Version of Migraine Treatment Imitrex
FDA Approves New Drug Treatment for Type 2 Diabetes

Latest Headlines

Zyprexa, Seroquel expanded to teenagers
December 7, 2009
Glaxo, Merck shots go head-to-head in U.S.
October 19, 2009
FDA: Political pressure led to device OK
September 25, 2009
Lundbeck's epilepsy med approved, J&J's rejected
August 24, 2009
King wins approval for anti-abuse painkiller Embeda
August 13, 2009
Avastin gets another FDA nod
August 3, 2009
Januvia gets head-to-head rival in Onglyza
August 3, 2009
FDA lets KRAS gene narrow drug use
July 20, 2009
How dangerous is Effient to Plavix?
July 13, 2009
Alimta nabs first lung-cancer maintenance use
July 7, 2009
FDA moves pump life back into Sanofi
July 2, 2009
ED drug gets nod as pulmonary ailment
May 26, 2009
UCB's Cimzia touted as potential top-seller
May 14, 2009
Diabetes drug gets FDA nod, but who'll sell it?
May 7, 2009
Avastin nabs quick glioblastoma OK
May 6, 2009
New generic competitors emerge for Topamax
March 30, 2009
Wyeth wins expanded indication for Tygacil
March 25, 2009
Lilly, Forest get new FDA indications
March 23, 2009
Pozen's shares soar as FDA approves study results
January 29, 2009
FDA approves Allergan's eyelash-growth drug
December 29, 2008

Paid Research Reports

More Research Reports >>